Back to search

Article

PNPLA3 <sup>I148M</sup> is a novel regulator of bone mass independent of MASLD

2026-03-17

Abstract excerpt

<h4>ABSTRACT</h4> Metabolic-dysfunction associated steatotic liver disease (MASLD) is the most common chronic liver disease. Fracture risk is increased among people with MASLD, however, the genetic contribution to risk is undetermined. PNPLA3 I148M is a common SNP which accounts for most MASLD heritability and increases MASLD morbidity and mortality. However, PNPLA3 I148M impact on bone is unexplored. To bridge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4e75bda2-4428-5553-9108-a7a0af0c4d4a
DOI
10.64898/2026.03.13.711662
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PNPLA3 <sup>I148M</sup> is a novel regulator of bone mass independent of MASLDDOI 10.64898/2026.03.13.711662
Select a neighboring publication to make it the new centre.